Where does Xtrava Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xtrava Inc. ranks #38,386 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xtrava Inc. hold?

Xtrava Inc. holds 7 US utility patents granted between 2019 and 2025, spanning 5 technology areas.

What is Xtrava Inc.'s Innovation Score?

Xtrava Inc. has an Innovation Score of 21.1 out of 100 (8th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Xtrava Inc. focus on?

Xtrava Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents. Grants appear in 5 CPC subclasses total.

Is Xtrava Inc.'s patent grant rate increasing or decreasing?

Xtrava Inc.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Xtrava Inc.'s patents?

Xtrava Inc.'s patents average 7.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xtrava Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Xtrava Inc.

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xtrava ranks #38,386 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#38,386
of 49,997 US assignees by volume: 8th percentile
by Innovation Score (21.1/100): 7.9
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R38386 · US Corporation #38,386 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
LOWER-Q #38,386/49,997
PHOTO-FINISH Xiamen Topstar…
CPC-NARROW A61B · 5 areas
INNOV-THIN 21.1/100
CLAIMS-SPARSE 7.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Xiamen Topstar Lighting Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Xtrava · this assignee

21
3D Lighting… · lowest

7

What this shows Xtrava's Innovation Score is 21.1/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Xtrava's grants concentrate

Xtrava Inc. is a focused PatentsView assignee: 5 CPC subclasses with 71.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2019. By volume, Xtrava sits between Xiamen Topstar Lighting Co., Ltd. and Yangtze Delta Region Institute (HUZHOU), University OF Electronic Science AND Technology OF China.

Xtrava's three-year grant acceleration

Xtrava Inc. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Xiamen Topstar Li…

7
Xiamen Weco Kitch…

7
Xiaomi H K

7
Xilio Development

7
Xuzhou Xcmg Excav…

7
Y-tex

7
Yamato Mishin Sei…

7
Yangtze Delta Reg…

7
Xtrava ◀

7

What this shows Xtrava holds 7 patents at rank #38,359, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xtrava

By rank, the assignees closest to #38,359 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Xtrava's primary technology class.

Xtrava's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Xtrava Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	14.3%
2020	3	42.9%
2021	1	14.3%
2024	1	14.3%
2025partial year	1	14.3%

Which technologies does Xtrava Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

H04W - Wireless Communication Networks 1

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#38,386

of 49,997 tracked assignees

Innovation Score

21.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Xtrava Inc.'s patent record in context - here's where to go next.

Xtrava Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 71.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #38,386 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xtrava Inc. against Xiamen Topstar Lighting Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 21.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.